CD8A and neoplasm: When the bioinformatics results were considered together, we found nine tumor types including LIHC, STAD, KIRC, UCEC, LUAD, SKCM, HNSC, CHOL, and GBM with ≥2 positive treatment-related molecular biological characteristics: high expression of ICB and lenvatinib target genes; high mutational loads and high frequency of driver alterations in lenvatinib and ICB target genes; negatively correlated with CD8+ T cell infiltration in lenvatinib target genes (Supplementary Table 2).